Literature DB >> 20429022

The role of statins in neurosurgery.

Jorge Humberto Tapia-Pérez1, Martin Sanchez-Aguilar, Thomas Schneider.   

Abstract

Statins are drugs used to control cholesterol disorders and prevent cardiovascular diseases. Their denominated pleiotropic effects have demonstrated a broad action spectrum that might profit some neurological and neurosurgical diseases. These effects are correlated to dose and kind of statin. We accomplished a systematic review in PubMed and MEDLINE about studies of statins and main neurosurgical diseases. If statins are administered after subarachnoid hemorrhage, a significant lower incidence of vasospasm as well as delayed ischemic deficits and decreased mortality could be found; the results of a large multicenter trial are expected. In other complex diseases as intracerebral hemorrhage or traumatic brain injury, the evidence for positive effects of a treatment with statin increased. Additionally, promising experimental results indicate that high statin doses are able to promote cell death in tumor cells, especially in gliomas. Moreover, experimental and observational studies suggest the ability of statins to modulate the immune system, by that they can reduce incidence and severity of sepsis. The origin of these multiple effects from neuroprotection to tumoral apoptosis is not totally explained so far. Recent data in literature are discussed in this review. More trials in humans are urgently required to finally determine if statins could contribute to the current management of neurosurgical diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429022     DOI: 10.1007/s10143-010-0259-4

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  110 in total

Review 1.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 2.  [Intervertebral disc pathologies from an immunological perspective].

Authors:  H Tapia-Pérez
Journal:  Rev Neurol       Date:  2008 Jun 16-30       Impact factor: 0.870

3.  Prior use of statins and outcome in patients with intracerebral haemorrhage.

Authors:  R Eichel; S T Khoury; T Ben-Hur; M Keidar; R Paniri; R R Leker
Journal:  Eur J Neurol       Date:  2009-07-09       Impact factor: 6.089

4.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

5.  Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone.

Authors:  Chih-Jung Yao; Gi-Ming Lai; Chin-Feng Chan; Ann-Lii Cheng; Ya-Yu Yang; Shuang-En Chuang
Journal:  Int J Cancer       Date:  2006-02-01       Impact factor: 7.396

6.  Angiogenesis and inflammatory cell infiltration in lumbar disc herniation.

Authors:  Yoichi Koike; Miwa Uzuki; Shoichi Kokubun; Takashi Sawai
Journal:  Spine (Phila Pa 1976)       Date:  2003-09-01       Impact factor: 3.468

Review 7.  Targeting eNOS for stroke protection.

Authors:  Matthias Endres; Ulrich Laufs; James K Liao; Michael A Moskowitz
Journal:  Trends Neurosci       Date:  2004-05       Impact factor: 13.837

8.  Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.

Authors:  X Zhang; A Patel; H Horibe; Z Wu; F Barzi; A Rodgers; S MacMahon; M Woodward
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

Review 9.  Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Andreas H Kramer; Jeffrey J Fletcher
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

10.  Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study.

Authors:  H Tapia-Perez; M Sanchez-Aguilar; J G Torres-Corzo; I Rodriguez-Leyva; D Gonzalez-Aguirre; A Gordillo-Moscoso; C Chalita-Williams
Journal:  Cent Eur Neurosurg       Date:  2009-02-05
View more
  5 in total

1.  A Prospective Safety Trial of Atorvastatin Treatment to Assess Rebleeding after Spontaneous Intracerebral Hemorrhage: A Serial MRI Investigation.

Authors:  R A Knight; T N Nagaraja; L Li; Q Jiang; K Tundo; M Chopp; D M Seyfried
Journal:  Austin J Cerebrovasc Dis Stroke       Date:  2016-07-20

2.  Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage.

Authors:  J H Tapia-Pérez; R Rupa; R Zilke; S Gehring; B Voellger; T Schneider
Journal:  Neurosurg Rev       Date:  2012-10-25       Impact factor: 3.042

Review 3.  Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury.

Authors:  Fatima A Sehba; Ryszard M Pluta; John H Zhang
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

4.  Use of statins and risk of glioma: a nationwide case-control study in Denmark.

Authors:  D Gaist; L Andersen; J Hallas; H Toft Sørensen; H D Schrøder; S Friis
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

Review 5.  To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Authors:  Giulia Cossu; Mahmoud Messerer; Mauro Oddo; Roy Thomas Daniel
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.